198 related articles for article (PubMed ID: 27497816)
1. Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer.
Kheshtchin N; Arab S; Ajami M; Mirzaei R; Ashourpour M; Mousavi N; Khosravianfar N; Jadidi-Niaragh F; Namdar A; Noorbakhsh F; Hadjati J
Cancer Immunol Immunother; 2016 Oct; 65(10):1159-67. PubMed ID: 27497816
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization and stromal imaging response correlates for the HIF-1 inhibitor PX-478 given with or without chemotherapy in pancreatic cancer.
Schwartz DL; Bankson JA; Lemos R; Lai SY; Thittai AK; He Y; Hostetter G; Demeure MJ; Von Hoff DD; Powis G
Mol Cancer Ther; 2010 Jul; 9(7):2057-67. PubMed ID: 20587661
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24
Minami T; Matsumura N; Sugimoto K; Shimizu N; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
Int Immunopharmacol; 2017 Mar; 44():197-202. PubMed ID: 28110220
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.
Welsh S; Williams R; Kirkpatrick L; Paine-Murrieta G; Powis G
Mol Cancer Ther; 2004 Mar; 3(3):233-44. PubMed ID: 15026543
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
Zhao T; Ren H; Jia L; Chen J; Xin W; Yan F; Li J; Wang X; Gao S; Qian D; Huang C; Hao J
Oncotarget; 2015 Feb; 6(4):2250-62. PubMed ID: 25544770
[TBL] [Abstract][Full Text] [Related]
7. Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem Cells
Cecil DL; Slota M; O'Meara MM; Curtis BC; Gad E; Dang Y; Herendeen D; Rastetter L; Disis ML
Clin Cancer Res; 2017 Jul; 23(13):3396-3404. PubMed ID: 28039264
[No Abstract] [Full Text] [Related]
8. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway.
Wang LM; Zhang LL; Wang LW; Zhu L; Ma XX
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10363-10369. PubMed ID: 31841190
[TBL] [Abstract][Full Text] [Related]
9. Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice.
Jacoby JJ; Erez B; Korshunova MV; Williams RR; Furutani K; Takahashi O; Kirkpatrick L; Lippman SM; Powis G; O'Reilly MS; Herbst RS
J Thorac Oncol; 2010 Jul; 5(7):940-9. PubMed ID: 20512076
[TBL] [Abstract][Full Text] [Related]
10. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
11. Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.
Paradziej-Łukowicz J; Skwarska A; Peszyńska-Sularz G; Brillowska-Dąbrowska A; Konopa J
Cancer Biol Ther; 2011 Oct; 12(7):586-97. PubMed ID: 21775820
[TBL] [Abstract][Full Text] [Related]
12. A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor.
Lee K; Kim HM
Arch Pharm Res; 2011 Oct; 34(10):1583-5. PubMed ID: 22076756
[TBL] [Abstract][Full Text] [Related]
13. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy.
Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS
Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091
[TBL] [Abstract][Full Text] [Related]
14. HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).
De Francesco EM; Lappano R; Santolla MF; Marsico S; Caruso A; Maggiolini M
Breast Cancer Res; 2013; 15(4):R64. PubMed ID: 23947803
[TBL] [Abstract][Full Text] [Related]
15. HIF-1alpha and cancer therapy.
Koh MY; Spivak-Kroizman TR; Powis G
Recent Results Cancer Res; 2010; 180():15-34. PubMed ID: 20033376
[TBL] [Abstract][Full Text] [Related]
16. Optimized Dose of Dendritic Cell-based Vaccination in Experimental Model of Tumor Using Artificial Neural Network.
Mirsanei Z; Habibi S; Kheshtchin N; Mirzaei R; Arab S; Zand B; Jadidi-Niaragh F; Safvati A; Sharif-Paghaleh E; Arabameri A; Asemani D; Hajati J
Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):172-182. PubMed ID: 32372630
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
[TBL] [Abstract][Full Text] [Related]
18. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
Pan X; Lv Y
Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
[TBL] [Abstract][Full Text] [Related]
19. The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer.
Luker AJ; Graham LJ; Smith TM; Camarena C; Zellner MP; Gilmer JS; Damle SR; Conrad DH; Bear HD; Martin RK
BMC Immunol; 2020 Feb; 21(1):8. PubMed ID: 32106810
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor 1 alpha limits dendritic cell stimulation of CD8 T cell immunity.
Tran CW; Gold MJ; Garcia-Batres C; Tai K; Elford AR; Himmel ME; Elia AJ; Ohashi PS
PLoS One; 2020; 15(12):e0244366. PubMed ID: 33382742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]